Latest News
Apple and Nokia settle, sign digital health deal
May 26, 2017Patent dispute solved, new multi-year licencing deal agreed.
Merck tries again in Alzheimer’s with Teijin’s tau antibody
May 26, 2017Target is implicated in a number of nervous system diseases.
GW close to filing cannabis-based epilepsy drug
May 25, 2017Epidiolex could become a blockbuster if approved in all uses.
This week’s news
AI-discovered candidates show promise in ALS
May 25, 2017Candidates slow down motor neurone death in patient samples.
FDA advisers back Puma breast cancer drug despite safety worries
May 25, 2017But biotech still has several hurdles to clear – including Roche’s rival.
Keytruda wins another first with approval based on biomarkers
May 24, 2017For the first time, FDA approves drug on the basis of biomarkers, rather than location.
Orbita, ERT seek to improve voice-first data capture
May 24, 2017Partnership to create voice-first solution letting researchers create and manage care plans.
Celgene MS pill can’t beat older rival on disability progression
May 24, 2017Phase 3 trial meets main efficacy endpoint, but disability progression stats cause concern.
Amgen/UCB’s osteoporosis drug hit by cardio risk
May 24, 2017Competitor to Amgen’s Epogen also moves closer to market
UK watchdog says MSD may have blocked Remicade biosimilars
May 23, 2017MSD may have abused dominant market position, says CMA.
Sanofi, Regeneron aim to undercut rivals with new RA drug
May 23, 2017New drug will be sold at around 30% discount to rivals.
Nokia, Kantar collaborate for diabetes database project
May 23, 2017Deal looks to measure impact of ‘Lifestyle Therapy’ on diabetes treatment.
AZ’s Bydureon disappoints in diabetes outcomes trial
May 23, 2017Results give advantage to Boehringer/Lilly’s Jardiance.
Semaglutide could transform diabetes treatment, revive Novo Nordisk revenues
May 22, 2017Oral formulation of GLP-1 drug could help cut heart attacks, tackle liver and kidney problems
Theresa May backtracks on ‘Dementia tax’
May 22, 2017Parties take out rival ads as social care funding row escalates.
European regulators back Chiesi COPD triple therapy
May 22, 2017Chiesi takes on Seretide and other lung drugs with Trimbow.
AZ sells beta-blocker rights to Recordati for $300m
May 22, 2017Italian pharma gets EU rights to Seloken.
